DE69127572T2 - Verwendung von Benzodiazepinverbindungen zur Herstellung eines Arzneimittels gegen mit excitatorischen Aminosäuren verbundene Zentralnervensystem-Störungen - Google Patents

Verwendung von Benzodiazepinverbindungen zur Herstellung eines Arzneimittels gegen mit excitatorischen Aminosäuren verbundene Zentralnervensystem-Störungen

Info

Publication number
DE69127572T2
DE69127572T2 DE69127572T DE69127572T DE69127572T2 DE 69127572 T2 DE69127572 T2 DE 69127572T2 DE 69127572 T DE69127572 T DE 69127572T DE 69127572 T DE69127572 T DE 69127572T DE 69127572 T2 DE69127572 T2 DE 69127572T2
Authority
DE
Germany
Prior art keywords
amino acids
nervous system
central nervous
excitatory amino
medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69127572T
Other languages
English (en)
Other versions
DE69127572D1 (de
Inventor
Leif Helth Jensen
Jorgen Drejer
Frank Waetjen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NTG Nordic Transport Group AS
Original Assignee
Neurosearch AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch AS filed Critical Neurosearch AS
Publication of DE69127572D1 publication Critical patent/DE69127572D1/de
Application granted granted Critical
Publication of DE69127572T2 publication Critical patent/DE69127572T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fats And Perfumes (AREA)
DE69127572T 1990-04-13 1991-03-27 Verwendung von Benzodiazepinverbindungen zur Herstellung eines Arzneimittels gegen mit excitatorischen Aminosäuren verbundene Zentralnervensystem-Störungen Expired - Fee Related DE69127572T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50928490A 1990-04-13 1990-04-13

Publications (2)

Publication Number Publication Date
DE69127572D1 DE69127572D1 (de) 1997-10-16
DE69127572T2 true DE69127572T2 (de) 1998-01-22

Family

ID=24026006

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69127572T Expired - Fee Related DE69127572T2 (de) 1990-04-13 1991-03-27 Verwendung von Benzodiazepinverbindungen zur Herstellung eines Arzneimittels gegen mit excitatorischen Aminosäuren verbundene Zentralnervensystem-Störungen

Country Status (12)

Country Link
EP (1) EP0451626B1 (de)
JP (1) JP3015129B2 (de)
AT (1) ATE157873T1 (de)
CA (1) CA2040242A1 (de)
DE (1) DE69127572T2 (de)
DK (1) DK0451626T3 (de)
ES (1) ES2108017T3 (de)
FI (1) FI911784A (de)
GR (1) GR3025186T3 (de)
IE (1) IE910939A1 (de)
NO (1) NO911449L (de)
PT (1) PT97365B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5317018A (en) * 1992-06-09 1994-05-31 Armin Walser Benzodiazepines and compositions for treating anxiety and panic disorders, and idiopathic and psychomotor epilepsy
ATE215079T1 (de) * 1992-07-24 2002-04-15 Univ California Arzneimittel, die den durch ampa rezeptoren vermittelten synaptischen respons erhöhen
US5852008A (en) * 1995-01-24 1998-12-22 The Regents Of The University Of California Heteroatom substituted benzoyl derivatives that enhance synaptic response mediated by receptors
GB2316616A (en) * 1996-09-02 1998-03-04 Lilly Industries Ltd Modulation of GluR5 receptors in the hippocampus to treat psychiatric disorders
KR102362725B1 (ko) * 2018-10-22 2022-02-15 (주)엘엑스하우시스 창호 시공용 낙하방지망 조립체

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MC1528A1 (fr) * 1982-07-21 1984-04-13 Hoffmann La Roche Imidazobenzodiazepines
CA1327008C (en) * 1988-01-15 1994-02-15 Walter Merz Anti-psychotic imidazobenzodiazepine

Also Published As

Publication number Publication date
CA2040242A1 (en) 1991-10-14
EP0451626A3 (en) 1992-10-07
EP0451626A2 (de) 1991-10-16
DE69127572D1 (de) 1997-10-16
DK0451626T3 (da) 1998-04-20
PT97365A (pt) 1992-01-31
ES2108017T3 (es) 1997-12-16
PT97365B (pt) 1998-08-31
ATE157873T1 (de) 1997-09-15
NO911449L (no) 1991-10-14
JP3015129B2 (ja) 2000-03-06
FI911784A (fi) 1991-10-14
GR3025186T3 (en) 1998-02-27
JPH04224516A (ja) 1992-08-13
IE910939A1 (en) 1991-10-23
NO911449D0 (no) 1991-04-12
EP0451626B1 (de) 1997-09-10
FI911784A0 (fi) 1991-04-12

Similar Documents

Publication Publication Date Title
FI941378A (fi) Bentsimidatsoliyhdisteitä, niiden käyttö ja valmistus
EA200000592A1 (ru) Азаполициклические соединения, конденсированные с арилом
DE69201948T2 (de) Verwendung von 1,3-oxathiolanalogen von nukleosiden zur herstellung eines arzneimittels zur behandlung von hepatitis-b.
ATE376998T1 (de) 1,2-diphenylpyrrol-derivate, ihre herstellung und therapeutische verwendung
ATE71090T1 (de) Heterocyclische verbindungen und deren herstellung und verwendung.
DE3888340D1 (de) Verwendung von 1,4-disubstituierten-Piperidinyl-Verbindungen zur Herstellung eines Arzneimittels zur Behandlung von Schlaflosigkeit.
ATE79257T1 (de) Verwendung von tetrahydrobenz(c,d>indol-6carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden.
ATE92316T1 (de) Verwendung von l-carnitinderivaten zur herstellung eines arzneimittels zur therapeutischen behandlung von peripheren neuropathien.
FI935800A (fi) Masennuksenvastaisia ja Parkinsonin taudin vastaisia yhdisteitä
DE69127572T2 (de) Verwendung von Benzodiazepinverbindungen zur Herstellung eines Arzneimittels gegen mit excitatorischen Aminosäuren verbundene Zentralnervensystem-Störungen
DE69421457T2 (de) Verwendung von N-(Pyridinyl)-1H-Indol-1-Aminen zur Herstellung eines Medikamentes zur Behandlung von zwangsneurotischen Erkrankungen
ATE236634T1 (de) Verwendung von 4-piperidinmethanolderivaten zur behandlung von neuralentwicklungsstörungen
ATE192650T1 (de) Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung parkinsonscher krankheit
ATE100102T1 (de) Substituierte derivate von 20,21dinoreburnamenin, verfahren zur herstellung und so hergestellte zwischenprodukte, ihre verwendung als arzneimittel und diese enthaltende pharmazeutische zusammenstellungen.
ATE212842T1 (de) Quinoxalin-derivate zur behandlung von tinnitus
IT1241927B (it) 3'-deamino-4'-deossi-4'-amino-8-fluoroantra- cicline processi per la loro preparazione e composizioni farmaceutiche che le contengono
ATE186912T1 (de) Carbamoylpyrrolidon-derivate zur behandlung von depressionen und cerebrovasculären störungen
ATE136217T1 (de) Verwendung von imino-derivaten von etianaldehyd zur herstellung eines arzneimittels zur behandlung des bluthochdrucks
DE69827706D1 (de) 5-(Heteroaryl)alkyl)-3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid (PBI) Derivate zur Behandlung von Störungen des zentralen Nervensystems

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee